Task: Answer the multiple choice question.
Question: Which drug exhibits a 14.075% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCCc1nc2oc3c(Cl)ncnc3c2c2c1CCCC2
b. CN1CCN(C2CC(=O)N(c3ccc4c(c3)OCCO4)C2=O)CC1.Cl
Answer: b. CN1CCN(C2CC(=O)N(c3ccc4c(c3)OCCO4)C2=O)CC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(C2CC(=O)N(c3ccc4c(c3)OCCO4)C2=O)CC1.Cl
CN1CCN(C2CC(=O)N(c3ccc4c(c3)OCCO4)C2=O)CC1.Cl
1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(4-methylpiperazin-1-yl)pyrrolidine-2,5-dione;hydrochloride